Exact Mass: 335.2268

Exact Mass Matches: 335.2268

Found 102 metabolites which its exact mass value is equals to given mass value 335.2268, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cetrimide

Tetradecyl trimethyl ammonium bromide

C17H38N. Br (335.2187)


Same as: D02164

   

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

[(4Z,6E,10Z,13Z)-1-carboxynonadeca-4,6,10,13-tetraen-8-yl]peroxy

C20H31O4 (335.2222)


This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.

   

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

[(4Z,7Z,11E,13Z)-1-carboxynonadeca-4,7,11,13-tetraen-10-yl]peroxy

C20H31O4 (335.2222)


This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.

   

Maybridge2_000465

Maybridge2_000465

C22H29N3 (335.2361)


   

polyavolensinone

polyavolensinone

C23H29NO (335.2249)


   

greenwayodendrin-3-one

greenwayodendrin-3-one

C23H29NO (335.2249)


   

(-)-4,4-Diphenyl-6-pyrrolidino-heptan-3-on|(-)-4,4-diphenyl-6-pyrrolidino-heptan-3-one

(-)-4,4-Diphenyl-6-pyrrolidino-heptan-3-on|(-)-4,4-diphenyl-6-pyrrolidino-heptan-3-one

C23H29NO (335.2249)


   

preindosespenone

preindosespenone

C23H29NO (335.2249)


   

N3-Ac,N8-Me,10-deoxy-搂脦-(2-Hydroxy-4-oxodecanoyl)histidine

N3-Ac,N8-Me,10-deoxy-搂脦-(2-Hydroxy-4-oxodecanoyl)histidine

C18H29N3O3 (335.2209)


   

Norpipanone

4,4-diphenyl-6-piperidin-1-ylhexan-3-one

C23H29NO (335.2249)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

3-N-BOC-AMINO-1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

C18H29N3O3 (335.2209)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(4-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(4-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

C18H29N3O3 (335.2209)


   

1-bromooctadecane-18,18,18-d3

1-bromooctadecane-18,18,18-d3

C18H34BrD3 (335.2267)


   

N,N,N-Tributyl-1-pentanaminium bromide

N,N,N-Tributyl-1-pentanaminium bromide

C17H38BrN (335.2187)


   

1-Deoxy-1-[methyl(nonanoyl)amino]-D-glucitol

1-Deoxy-1-[methyl(nonanoyl)amino]-D-glucitol

C16H33NO6 (335.2308)


   

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate

C18H30BNO4 (335.2268)


   

Myristyltrimethylammonium bromide

Tetradecyltrimethylammonium bromide

C17H38BrN (335.2187)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents

   

leukotriene B4(1-)

leukotriene B4(1-)

C20H31O4- (335.2222)


The leukotriene anion that is the conjugate base of leukotriene B4 arising from deprotonation of the carboxylic acid function.

   

(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate

(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate

C20H31O4- (335.2222)


   

(5Z,8Z,10E,12S,14Z)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate

(5Z,8Z,10E,12S,14Z)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate

C20H31O4- (335.2222)


   

15(S)-Hpete(1-)

15(S)-Hpete(1-)

C20H31O4- (335.2222)


Conjugate base of 15(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate

(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate

C20H31O4- (335.2222)


Conjugate base of (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic acid arising from deprotonation of the carboxylic acid function.

   

(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate

(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate

C20H31O4- (335.2222)


   

(5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate

(5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate

C20H31O4- (335.2222)


   

(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate

(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate

C20H31O4- (335.2222)


   

15(R)-Hpete(1-)

15(R)-Hpete(1-)

C20H31O4- (335.2222)


A hydroperoxy fatty acid anion that is the conjugate base of 15(R)-HPETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoate

(8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoate

C20H31O4- (335.2222)


An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoate

(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoate

C20H31O4- (335.2222)


An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoate

(10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoate

C20H31O4- (335.2222)


An unsaturated fatty acid anion that is the conjugate base of (10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-Oate

(13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-Oate

C20H31O4- (335.2222)


   

7-[(1R,2S)-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate

7-[(1R,2S)-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate

C20H31O4- (335.2222)


   

(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate

(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate

C20H31O4- (335.2222)


   

(5Z,8Z,14Z)-(11R,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoate

(5Z,8Z,14Z)-(11R,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoate

C20H31O4- (335.2222)


   

(5S,7E,9E,11Z,13E,15S)-5,15-dihydroxyicosa-7,9,11,13-tetraenoate

(5S,7E,9E,11Z,13E,15S)-5,15-dihydroxyicosa-7,9,11,13-tetraenoate

C20H31O4- (335.2222)


   

(5Z,11Z,14Z)-(8S,9S,10R)-10-hydroxy-8,9-epoxyicosa-5,11,14-trienoate

(5Z,11Z,14Z)-(8S,9S,10R)-10-hydroxy-8,9-epoxyicosa-5,11,14-trienoate

C20H31O4- (335.2222)


   

prostaglandin A1(1-)

prostaglandin A1(1-)

C20H31O4- (335.2222)


Conjugate base of prostaglandin A1.

   

Prostaglandin C1(1-)

Prostaglandin C1(1-)

C20H31O4- (335.2222)


Conjugate base of prostaglandin C1.

   

5-Hpete(1-)

5-Hpete(1-)

C20H31O4- (335.2222)


A HPETE anion that is the conjugate base of 5-HPETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

15-Hpete(1-)

15-Hpete(1-)

C20H31O4- (335.2222)


A HPETE anion that is the conjugate base of 15-HPETE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

5(S),15(S)-DiHETE(1-)

5(S),15(S)-DiHETE(1-)

C20H31O4- (335.2222)


An icosanoid anion that is the conjugate base of 5(S),15(S)-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5(S),11(R)-DiHETE(1-)

5(S),11(R)-DiHETE(1-)

C20H31O4- (335.2222)


An icosanoid anion that is the conjugate base of 5(S),11(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5(S),15(R)-DiHETE(1-)

5(S),15(R)-DiHETE(1-)

C20H31O4- (335.2222)


An icosanoid anion that is the conjugate base of 5(S),15(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

hepoxilin A3(1-)

hepoxilin A3(1-)

C20H31O4- (335.2222)


A hepoxilin anion that is the conjugate base of hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

hepoxilin B3(1-)

hepoxilin B3(1-)

C20H31O4- (335.2222)


A hepoxilin anion that is the conjugate base of hepoxilin B3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8S)-hepoxilin A3(1-)

(8S)-hepoxilin A3(1-)

C20H31O4- (335.2222)


A hepoxilin A3 anion that is the conjugate base of (8S)-hepoxilin A3, obtained by deprotonation of the carboxylic acid group; major species at pH 7.3.

   

6-trans-leukotriene B4(1-)

6-trans-leukotriene B4(1-)

C20H31O4- (335.2222)


A leukotriene anion that is the conjugate base of 6-trans-leukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

8,20-DiHETE(1-)

8,20-DiHETE(1-)

C20H31O4- (335.2222)


An icosanoid anion that is the conjugate base of 8,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5,20-DiHETE(1-)

5,20-DiHETE(1-)

C20H31O4- (335.2222)


An icosanoid anion that is the conjugate base of 5,20-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

9(R)-Hpete(1-)

9(R)-Hpete(1-)

C20H31O4- (335.2222)


A HPETE anion obtained by deprotonation of the carboxy group of 9(R)-HPETE; major species at pH 7.3.

   

12,20-DiHETE(1-)

12,20-DiHETE(1-)

C20H31O4- (335.2222)


An icosanoid anion that is the conjugate base of 12,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1-)

11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1-)

C20H31O4- (335.2222)


An hepoxilin anion that is the conjugate base of 11(S)-hydroxy-14(S),15(S)-hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoate

(8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoate

C20H31O4- (335.2222)


An unsaturated fatty acid anion that is the conjugate base of (8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoate

(7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoate

C20H31O4- (335.2222)


A polyunsaturated fatty acid anion that is the conjugate base of (7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoate

(13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoate

C20H31O4- (335.2222)


An unsaturated fatty acid anion that is the conjugate base of (13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoate

(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoate

C20H31O4- (335.2222)


   

(5Z,8Z,11Z,13S)-13-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z,13S)-13-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222)


   

5(R)-HPETE anion

5(R)-HPETE anion

C20H31O4- (335.2222)


   
   
   

12-oxo-(5S)-Hydroxy-(6Z,8E,14Z)-eicosatrienoate

12-oxo-(5S)-Hydroxy-(6Z,8E,14Z)-eicosatrienoate

C20H31O4- (335.2222)


   

(5S,6E,10E,12E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

(5S,6E,10E,12E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C20H31O4- (335.2222)


   

(5Z,8Z,11Z)-13-[3-(5-hydroxypentyl)oxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-[3-(5-hydroxypentyl)oxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222)


   

(5Z,8S,9E,11Z,13E,15S)-8,15-dihydroxyicosa-5,9,11,13-tetraenoate

(5Z,8S,9E,11Z,13E,15S)-8,15-dihydroxyicosa-5,9,11,13-tetraenoate

C20H31O4- (335.2222)


   

(5Z,8Z,11Z)-13-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222)


   

(5Z)-7-{3-[(2Z,5Z)-11-hydroxyundeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate

(5Z)-7-{3-[(2Z,5Z)-11-hydroxyundeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate

C20H31O4- (335.2222)


   

(5Z,8Z)-10-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate

(5Z,8Z)-10-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate

C20H31O4- (335.2222)


   

(5S,6R,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

(5S,6R,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

C20H31O4- (335.2222)


   
   

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.2209)


   

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.2209)


   

(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.2209)


   

(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.2209)


   

(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.2209)


   

(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.2209)


   

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.2209)


   

(5Z,8Z,10E,12E,14R,15S)-14,15-dihydroxyicosa-5,8,10,12-tetraenoate

(5Z,8Z,10E,12E,14R,15S)-14,15-dihydroxyicosa-5,8,10,12-tetraenoate

C20H31O4- (335.2222)


   

(5Z,8Z,11Z)-13-hydroxy-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-hydroxy-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate

C20H31O4- (335.2222)


   

9(S)-Hpete(1-)

9(S)-Hpete(1-)

C20H31O4- (335.2222)


   

(5Z,8Z,12E)-11-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoate

(5Z,8Z,12E)-11-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoate

C20H31O4- (335.2222)


   

4-{3-[(2Z,5Z,8Z)-14-hydroxytetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate

4-{3-[(2Z,5Z,8Z)-14-hydroxytetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate

C20H31O4- (335.2222)


   

(5S,6S,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

(5S,6S,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

C20H31O4- (335.2222)


   

MTAB

Tetradecyltrimethylammonium bromide

C17H38N. Br (335.2187)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents Same as: D02164

   

5(S)-HPETE(1-)

5(S)-HPETE(1-)

C20H31O4 (335.2222)


Conjugate base of 5(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

8(R)-HPETE(1-)

8(R)-HPETE(1-)

C20H31O4 (335.2222)


Conjugate base of 8(R)-HPETE arising from deprotonation of the carboxylic acid function.

   

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

C20H31O4 (335.2222)


   

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

C20H31O4 (335.2222)


   

8(S),15(S)-DiHETE(1-)

8(S),15(S)-DiHETE(1-)

C20H31O4 (335.2222)


A DiHETE(1-) that is the conjugate base of 8(S),15(S)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

8(S)-HPETE(1-)

8(S)-HPETE(1-)

C20H31O4 (335.2222)


A HPETE anion obtained by deprotonation of the carboxy group of (8S)-HPETE.

   

14(R),15(S)-DiHETE(1-)

14(R),15(S)-DiHETE(1-)

C20H31O4 (335.2222)


A DiHETE(1-) that is the conjugate base of 14(R),15(S)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoate

11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoate

C20H31O4 (335.2222)


An epoxy(hydroxy)icosatrienoate that is the conjugate base of 11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

12(R)-HPETE(1-)

12(R)-HPETE(1-)

C20H31O4 (335.2222)


A hydroperoxy fatty acid anion that is the conjugate base of 12(R)-HPETE, obtained by deprotonation of the carboxy group.

   

(13S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate

(13S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate

C20H31O4 (335.2222)


A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoate that is the conjugate base of 13(S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate(1-)

13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate(1-)

C20H31O4 (335.2222)


A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoate that is the conjugate base of 13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin B1(1-)

prostaglandin B1(1-)

C20H31O4 (335.2222)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin B1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

12(S)-HPETE(1-)

12(S)-HPETE(1-)

C20H31O4 (335.2222)


Conjugate base of 12(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

11(R)-HPETE(1-)

11(R)-HPETE(1-)

C20H31O4 (335.2222)


A hydroperoxy fatty acid anion that is the conjugate base of 11(R)-HPETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(1r,12r,13s,18r)-1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one

(1r,12r,13s,18r)-1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one

C23H29NO (335.2249)


   

12,13,17,17-tetramethyl-3-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹⁶,²⁰]icosa-2(10),4,6,8,16(20)-pentaen-18-ol

12,13,17,17-tetramethyl-3-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹⁶,²⁰]icosa-2(10),4,6,8,16(20)-pentaen-18-ol

C23H29NO (335.2249)


   

(1s,12r,13r,18s)-12,13,17,17-tetramethyl-3-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹⁶,²⁰]icosa-2(10),4,6,8,16(20)-pentaen-18-ol

(1s,12r,13r,18s)-12,13,17,17-tetramethyl-3-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹⁶,²⁰]icosa-2(10),4,6,8,16(20)-pentaen-18-ol

C23H29NO (335.2249)


   

1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one

1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one

C23H29NO (335.2249)


   

(1r,12s,13s,18r)-1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one

(1r,12s,13s,18r)-1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one

C23H29NO (335.2249)